Aaron Brzezinski

5.5k total citations
70 papers, 3.9k citations indexed

About

Aaron Brzezinski is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Aaron Brzezinski has authored 70 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Genetics, 41 papers in Epidemiology and 30 papers in Surgery. Recurrent topics in Aaron Brzezinski's work include Inflammatory Bowel Disease (49 papers), Microscopic Colitis (34 papers) and Eosinophilic Esophagitis (11 papers). Aaron Brzezinski is often cited by papers focused on Inflammatory Bowel Disease (49 papers), Microscopic Colitis (34 papers) and Eosinophilic Esophagitis (11 papers). Aaron Brzezinski collaborates with scholars based in United States, Canada and Zambia. Aaron Brzezinski's co-authors include Bret A. Lashner, Victor W. Fazio, Bo Shen, Feza H. Remzi, Jean-Paul Achkar, Charles Bevins, Marlene L. Bambrick, Ana E. Bennett, A.H. Steinhart and Adrian Ormsby and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Medicine.

In The Last Decade

Aaron Brzezinski

69 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron Brzezinski United States 32 2.8k 2.1k 1.7k 795 370 70 3.9k
A. Pera Italy 33 2.8k 1.0× 2.3k 1.1× 1.8k 1.1× 518 0.7× 443 1.2× 69 4.3k
Jean-Paul Achkar United States 24 2.0k 0.7× 1.4k 0.7× 1.2k 0.7× 495 0.6× 367 1.0× 31 2.9k
Gottfried Novacek Austria 26 1.8k 0.6× 1.6k 0.8× 1.2k 0.7× 403 0.5× 236 0.6× 103 3.3k
Gunnar Olaison Sweden 33 2.1k 0.7× 1.6k 0.8× 2.0k 1.2× 343 0.4× 360 1.0× 75 3.9k
Bernard Duclos France 31 2.1k 0.7× 1.6k 0.8× 922 0.6× 180 0.2× 371 1.0× 100 3.6k
Íngrid Ordás Spain 31 4.6k 1.6× 3.2k 1.5× 2.2k 1.3× 590 0.7× 643 1.7× 86 6.3k
Timothy R. Orchard United Kingdom 24 2.7k 1.0× 2.0k 0.9× 1.1k 0.7× 222 0.3× 259 0.7× 51 4.0k
Gwo‐Tzer Ho United Kingdom 29 2.5k 0.9× 1.8k 0.8× 1.1k 0.7× 227 0.3× 517 1.4× 65 3.9k
H Malchow Germany 22 2.6k 0.9× 2.0k 1.0× 1.1k 0.7× 316 0.4× 220 0.6× 52 3.5k
Klaus Ewe Germany 20 1.7k 0.6× 1.4k 0.6× 930 0.6× 365 0.5× 159 0.4× 48 3.0k

Countries citing papers authored by Aaron Brzezinski

Since Specialization
Citations

This map shows the geographic impact of Aaron Brzezinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Brzezinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Brzezinski more than expected).

Fields of papers citing papers by Aaron Brzezinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Brzezinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Brzezinski. The network helps show where Aaron Brzezinski may publish in the future.

Co-authorship network of co-authors of Aaron Brzezinski

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Brzezinski. A scholar is included among the top collaborators of Aaron Brzezinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Brzezinski. Aaron Brzezinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mukewar, Saurabh, Meagan Costedio, Xianrui Wu, et al.. (2014). Severe Adverse Outcomes of Endoscopic Perforations in Patients with and Without IBD. Inflammatory Bowel Diseases. 20(11). 2056–2066. 29 indexed citations
2.
Atreja, Ashish, Ashish Aggarwal, Florian Rieder, et al.. (2013). Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn's disease strictures. Journal of Crohn s and Colitis. 8(5). 392–400. 65 indexed citations
3.
Wang, Yinghong, Ashish Atreja, Xianrui Wu, et al.. (2013). Similar Outcomes of IBD Inpatients with Clostridium difficile Infection Detected by ELISA or PCR Assay. Digestive Diseases and Sciences. 58(8). 2308–2313. 17 indexed citations
4.
Lewis, Brian, et al.. (2013). Frequency and Risk Factors of Renal Insufficiency in Inflammatory Bowel Disease Inpatients. Inflammatory Bowel Diseases. 19(9). 1–1. 35 indexed citations
5.
Shen, Bo, Feza H. Remzi, Ioannis Oikonomou, et al.. (2009). Risk Factors for Low Bone Mass in Patients With Ulcerative Colitis Following Ileal Pouch-Anal Anastomosis. The American Journal of Gastroenterology. 104(3). 639–646. 30 indexed citations
6.
Shen, Bo, et al.. (2008). Application of Wireless Capsule Endoscopy for the Evaluation of Iron Deficiency Anemia in Patients With Ileal Pouches. Journal of Clinical Gastroenterology. 42(8). 897–902. 10 indexed citations
7.
Shen, Bo, Victor W. Fazio, Feza H. Remzi, et al.. (2007). Combined Ciprofloxacin and Tinidazole Therapy in the Treatment of Chronic Refractory Pouchitis. Diseases of the Colon & Rectum. 50(4). 498–508. 87 indexed citations
8.
Shen, Bo, Victor W. Fazio, Feza H. Remzi, et al.. (2006). Risk Factors for Clinical Phenotypes of Crohn's Disease of the Ileal Pouch. The American Journal of Gastroenterology. 101(12). 2760–2768. 79 indexed citations
9.
Achkar, Jean-Paul, Mohammad Al‐Haddad, Bret A. Lashner, et al.. (2005). Differentiating risk factors for acute and chronic pouchitis. Clinical Gastroenterology and Hepatology. 3(1). 60–66. 125 indexed citations
10.
Shen, Bo, Aaron Brzezinski, V. W. Fazio, et al.. (2005). Maintenance therapy with a probiotic in antibiotic‐dependent pouchitis: experience in clinical practice. Alimentary Pharmacology & Therapeutics. 22(8). 721–728. 111 indexed citations
11.
Seidner, Douglas L., Bret A. Lashner, Aaron Brzezinski, et al.. (2005). An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: A randomized, controlled trial. Clinical Gastroenterology and Hepatology. 3(4). 358–369. 88 indexed citations
12.
Shen, Bo, Bret A. Lashner, Ana E. Bennett, et al.. (2004). Treatment of Rectal Cuff Inflammation (Cuffitis) in Patients with Ulcerative Colitis Following Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis. The American Journal of Gastroenterology. 99(8). 1527–1531. 105 indexed citations
13.
Stevens, Tyler, J ACHKAR, Kirk A. Easley, Aaron Brzezinski, & Bret A. Lashner. (2004). Azathioprine formulation optimizes metabolite profile in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 20(6). 601–606. 6 indexed citations
14.
Parsi, Mansour A., Bret A. Lashner, Jean-Paul Achkar, Jason T. Connor, & Aaron Brzezinski. (2004). Type of Fistula Determines Response to Infliximab in Patients with Fistulous Crohn's Disease. The American Journal of Gastroenterology. 99(3). 445–449. 80 indexed citations
15.
Shen, Bo, Jean-Paul Achkar, Jason T. Connor, et al.. (2003). Modified Pouchitis Disease Activity Index. Diseases of the Colon & Rectum. 46(6). 748–753. 223 indexed citations
16.
Brant, Steven R., Michael F. Picco, Jean-Paul Achkar, et al.. (2003). Defining Complex Contributions of NOD2/CARD15 Gene Mutations, Age at Onset, and Tobacco Use On Crohn's Disease Phenotypes. Inflammatory Bowel Diseases. 9(5). 281–289. 172 indexed citations
17.
Tremaine, WJ, Aaron Brzezinski, Jeffrey A. Katz, et al.. (2002). Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open‐label pilot study. Alimentary Pharmacology & Therapeutics. 16(3). 407–413. 75 indexed citations
18.
Shen, Bo, Jean-Paul Achkar, Bret A. Lashner, et al.. (2001). A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute Pouchitis. Inflammatory Bowel Diseases. 7(4). 301–305. 234 indexed citations
19.
Shetty, Kirti, Lisa Rybicki, Aaron Brzezinski, William D. Carey, & Bret A. Lashner. (1999). The Risk for Cancer Or Dysplasia in Ulcerative Colitis Patients With Primary Sclerosing Cholangitis. The American Journal of Gastroenterology. 94(6). 1643–1649. 156 indexed citations
20.
Steinhart, A. Hillary, Jeffrey P. Baker, Aaron Brzezinski, & E. J. Prokipchuk. (1990). Azathioprine Therapy in Chronic Ulcerative Colitis. Journal of Clinical Gastroenterology. 12(3). 271–275. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Pera Breakdown of academic impact, for papers by Jean-Paul Achkar Breakdown of academic impact, for papers by Gottfried Novacek Breakdown of academic impact, for papers by Gunnar Olaison Breakdown of academic impact, for papers by Bernard Duclos Breakdown of academic impact, for papers by Íngrid Ordás Breakdown of academic impact, for papers by Timothy R. Orchard Breakdown of academic impact, for papers by Gwo‐Tzer Ho Breakdown of academic impact, for papers by H Malchow Breakdown of academic impact, for papers by Klaus Ewe
Rankless by CCL
2026